Adolescent and young adult nicotine vaping has become an urgent public health concern, as 2024 marked the first year that ...
Medically reviewed by Kashif J. Piracha, MD Key Takeaways You can get addicted to nicotine within days of starting to use it.
E-cigarettes and varenicline (Chantix) helped long-time smokers quit conventional cigarettes at similar rates in the short term, but the benefit was more lasting with varenicline, according to a ...
TUESDAY, May 21, 2024 (HealthDay News) -- A quit-smoking drug appears to help people drop their vaping addiction, a new study shows. Vapers who took varenicline (Chantix) were significantly more ...
A quit-smoking drug might help patients quit vaping as well Significantly more patients quit when taking varenicline than when taking a placebo Larger trials are needed TUESDAY, May 21, 2024 ...
Increasing the dosages of varenicline (Chantix) or combined nicotine replacement therapy (CNRT), or switching from CNRT to varenicline, improved abstinence from smoking, a randomized clinical trial ...
African Americans have been underrepresented in tobacco treatment research, including the clinical trials that led to the 2006 FDA approval of varenicline, the leading pharmacological treatment for ...
(RTTNews) - Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence ...
Please provide your email address to receive an email when new articles are posted on . Pfizer has voluntarily expanded its recall of Chantix 0.5 mg and 1 mg tablets because of the presence of the ...
Pfizer is expanding the recall of its anti-smoking drug Chantix, also known as varenicline, the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted ...
Pfizer is voluntarily recalling all lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer. According to the notice posted on the Food and ...